CytomX Therapeutics (CTMX) Other Working Capital Changes (2014 - 2026)
CytomX Therapeutics' (CTMX) quarterly Other Working Capital Changes came in at -$9.6 million in Q1 2026, up 78.46% YoY from -$5.4 million in Q1 2025, and down 1844.46% on a QoQ basis from $551000.0 in Q4 2025.
CytomX Therapeutics (CTMX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
CytomX Therapeutics (CTMX) has 9 years of Other Working Capital Changes data on file, last reported at -$9.6 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 78.46% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.6 million (up 77.16% YoY) and the FY2025 annual result came in at -$65.6 million, up 44.53% from the prior year.
- Other Working Capital Changes fell to -$9.6 million in Q1 2026, from $551000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.2 million in Q4 2022 to a low of -$1.6 million in Q2 2023.
- A 5-year average of $86000.0 and a median of -$1000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 543.47% — and 2023, when it sank 159.63%.
- Tracing CTMX's Other Working Capital Changes over 5 years: stood at $45.9 million in 2022, then tumbled by 153.07% to -$24.3 million in 2023, then sank by 46.07% to -$35.6 million in 2024, then jumped by 101.55% to $551000.0 in 2025, then plunged by 1844.46% to -$9.6 million in 2026.
- The last three Other Working Capital Changes figures came in at -$9.6 million (Q1 2026), $551000.0 (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.86 Mn |
| Jun 30, 2026 | 2.86 Mn |
| Jun 30, 2026 | 2.86 Mn |
| Mar 31, 2026 | 887,000.00 |
| Mar 31, 2026 | 887,000.00 |
| Mar 31, 2026 | 887,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Dec 31, 2025 | 874,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Sep 30, 2025 | -708,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 335,000.00 |
| Dec 31, 2024 | 335,000.00 |